Zingiber officinale Roscoe alone and in combination with α-tocopherol protect the kidney against cisplatin-induced acute renal failure

被引:92
作者
Ajith, T. A. [1 ]
Nivitha, V. [1 ]
Usha, S. [1 ]
机构
[1] Amala Inst Med Sci, Dept Biochem, Trichur 680555, Kerala, India
关键词
antioxidant; free radicals; nephrotoxicity; Zingiber officinale;
D O I
10.1016/j.fct.2006.11.014
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Oxidative stress due to abnormal production of reactive oxygen molecules (ROM) is believed to be involved in the etiology of toxicities of many xenobiotics. Evidences suggested that ROM is involved in the nephrotoxicity of a widely used synthetic anticancer drug cisplatin. The nephroprotective effects of ethanol extract of Zingiber officinale alone and in combination with vitamin E (alpha-tocopherol) were evaluated using cisplatin (single dose of 10 mg/kg body wt, i.p) induced acute renal damage in mice. The results of the study indicated that Z officinale significantly and dose dependently protected the nephrotoxicity induced by cisplatin. The serum urea and creatinine levels in the cisplatin alone treated group were significantly elevated (P < 0.01) with respect to normal group of animals. The levels were reduced in the Z. officinale (250 and 500 mg/kg, p.o) plus cisplatin, vitamin E (250 mg/kg) plus cisplatin, and Z. officinale (250 mg/kg) with vitamin E plus vitamin E treated groups. The renal antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) activities and level of reduced glutathione (GSH) were declined; level of malondialdehyde (MDA) was elevated in the cisplatin alone treated group. The activities of SOD, CAT GPx and level of GSH were elevated and level of MDA declined significantly (P < 0.05) in the Z. officinale (250 and 500 mg/kg) plus cisplatin and Z. officinale (250 mg/kg) with vitamin E plus cisplatin treated groups. The protective effect of Z officinale (250 mg/kg body wt) was found to be better than that of vitamin E (250 mg/ kg body wt). The results also demonstrated that combination of Z. officinale (250 mg/kg) with vitamin E (250 mg/kg) showed a better protection compared to their 250 mg/kg alone treated groups. This study concluded that ethanol extract of Z. officinale alone and in combination with vitamin E partially ameliorated cisplatin-induced nephrotoxicity. This protection is mediated either by preventing the cisplatin-induced decline of renal antioxidant defense system or by their direct free radical scavenging activity. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:921 / 927
页数:7
相关论文
共 38 条
[1]  
Ajith TA, 2002, J EXP CLIN CANC RES, V21, P213
[2]   PROTECTION AGAINST CISPLATIN TOXICITY BY ADMINISTRATION OF GLUTATHIONE ESTER [J].
ANDERSON, ME ;
NAGANUMA, A ;
MEISTER, A .
FASEB JOURNAL, 1990, 4 (14) :3251-3255
[3]   A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF GINGER FOR THE PREVENTION OF POSTOPERATIVE NAUSEA AND VOMITING [J].
ARFEEN, Z ;
OWEN, H ;
PLUMMER, JL ;
ILSLEY, AH ;
SORBYADAMS, RAC ;
DOECKE, CJ .
ANAESTHESIA AND INTENSIVE CARE, 1995, 23 (04) :449-452
[4]   CISPLATIN-INDUCED NEPHROTOXICITY AND THE MODULATING EFFECT OF GLUTATHIONE ESTER [J].
BABU, E ;
GOPALAKRISHNAN, VK ;
SRIGANTH, INP ;
GOPALAKRISHNAN, R ;
SAKTHISEKARAN, D .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1995, 144 (01) :7-11
[5]  
BEERS RF, 1952, J BIOL CHEM, V195, P133
[6]   4-METHYLTHIOBENZOIC ACID REDUCES CISPLATIN NEPHROTOXICITY IN RATS WITHOUT COMPROMISING ANTITUMOR-ACTIVITY [J].
BOOGAARD, PJ ;
LEMPERS, ELM ;
MULDER, GJ ;
MEERMAN, JHN .
BIOCHEMICAL PHARMACOLOGY, 1991, 41 (12) :1997-2003
[7]   Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues:: possible protective roles of natural antioxidant foods [J].
Çetin, R ;
Devrim, E ;
Kiliçoglu, B ;
Avci, A ;
Çandir, Ö ;
Durak, I .
JOURNAL OF APPLIED TOXICOLOGY, 2006, 26 (01) :42-46
[8]  
CONNEY AH, 1982, CANCER RES, V42, P4875
[9]   CISPLATIN-INDUCED LOSS OF KIDNEY COPPER AND NEPHROTOXICITY IS AMELIORATED BY SINGLE DOSE DIETHYLDITHIOCARBAMATE, BUT NOT MESNA [J].
DEWOSKIN, RS ;
RIVIERE, JE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1992, 112 (02) :182-189
[10]  
GANDARA DR, 1991, SEMIN ONCOL, V18, P49